Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score‐matched study
International Journal of Urology · 2025
DOI: 10.1111/iju.15610 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, 2025. Verfasst von Kenjiro Kishitani und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Nephrectomy, Kidney Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Surgical treatment for renal cell carcinoma (RCC) has drastically evolved for the past 30 years. However, survival outcomes of RCC according to times have not been fully elucidated, especially in the real‐world setting. This study aimed to assess the survival improvement over time in RCC treated with nephrectomy by analyzing a longitudinal cohort using propensity score matching (PSM).
Methods
We retrospectively reviewed 960 patients with RCC who underwent radical or partial nephrectomy between 1981 and 2018. Patients were divided into two groups according to the time of surgery (1981–1999 vs. 2000–2018). Using PSM, overall survival (OS), cancer‐specific survival (CSS), and recurrence‐free survival (RFS) were compared between the two groups.
Results
Overall, 255 and 705 patients underwent surgery in the earlier (1981–1999) and recent (2000–2018) eras, and PSM derived a matched cohort of 466 patients (233 patients per each group). All patients in the earlier era cohort received open surgeries, whereas about a half (47.4%) of patients in the recent era cohort received minimally‐invasive (laparoscopic/robotic) surgeries. After PSM, 137 (29.4%) patients developed recurrence, 105 (22.5%) died of RCC, and 113 (24.2%) died from other causes, with a median follow‐up period of 90 months. The recent era cohort had significantly longer OS, CSS, and RFS than the earlier era cohort.
Conclusions
Patients with RCC treated in the recent era (2000–2018) showed significantly longer survival than those treated in the earlier era (1981–1999). The improved survival might be attributable to the prevalence of minimally‐invasive (laparoscopic/robotic) surgeries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
ORCID-Profile: Satoru Taguchi, Yuta Yamada, Aya Niimi
Zitieren
APA
Kishitani, K., Taguchi, S., Tanaka, K., Danno, T., Oshina, T., Fujii, Y., Kamei, J., Akiyama, Y., Kakutani, S., Sato, Y., Yamada, Y., Niimi, A., Yamada, D., & Kume, H. (2025). Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score‐matched study. International Journal of Urology. https://doi.org/10.1111/iju.15610
Vancouver
Kishitani K, Taguchi S, Tanaka K, Danno T, Oshina T, Fujii Y, et al. Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score‐matched study. International Journal of Urology. 2025. doi:10.1111/iju.15610
BibTeX
@article{Kishitani2025,
author = {Kishitani, Kenjiro and Taguchi, Satoru and Tanaka, Koji and Danno, Tetsuya and Oshina, Takahiro and Fujii, Yoichi and Kamei, Jun and Akiyama, Yoshiyuki and Kakutani, Shigenori and Sato, Yusuke and Yamada, Yuta and Niimi, Aya and Yamada, Daisuke and Kume, Haruki},
title = {Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score‐matched study},
journal = {International Journal of Urology},
year = {2025},
doi = {10.1111/iju.15610}
}
EUVIMED